KLOW 80mg

KLOW is engineered as a multi-targeted peptide matrix, combining four complementary tissue-repair compounds—KPV, GHK-Cu, BPC-157, and TB-500—in precise ratios to facilitate advanced research in systemic cellular regeneration and extracellular matrix remodeling.

• Angiogenesis & Tissue Remodeling (BPC-157 & TB-500): Promotes microvascular formation, cell migration, and actin-cytoskeleton organization, optimizing investigation into tendon, ligament, and mucosal tissue recovery.

• Collagen Synthesis & Anti-Inflammatory Signaling (GHK-Cu & KPV): Enhances copper-mediated collagen/elastin gene expression while suppressing pro-inflammatory cytokines via targeted NF-κB inhibition for dermatological and anti-fibrotic studies.

While single-peptide models isolate individual biological mechanisms, KLOW’s multi-pathway formulation co-activates systemic cellular migration, dermal structural synthesis, and acute inflammatory attenuation—allowing researchers to investigate compound wound-healing cascades and tissue restoration without administering multiple independent monotherapies.

Disclaimer: This product is sold strictly for research purposes only. Not for human consumption, clinical trials, or therapeutic use.

KLOW Lot001 COA